Clearfield Capital Management LP Elanco Animal Health Inc Transaction History

Clearfield Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$21.1 - $29.13 $20.3 Million - $28.1 Million	-963,100 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$18.94 - $24.93 $18.2 Million - $24 Million	963,100 New	963,100 $20.7 Million
Q3 2019 Nov 13, 2019	SELL	$25.62 - $34.96 $21.2 Million - $28.9 Million	-825,683 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$31.11 - $34.79 $12.9 Million - $14.4 Million	-414,517 Reduced 33.42%	825,683 $27.9 Million
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $36 Million - $40.7 Million	1,240,200 New	1,240,200 $39.8 Million

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Clearfield Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Clearfield Capital Management LP with notifications on news.